Protara Therapeutics, Inc. Restricted Cash and Investments
Protara Therapeutics, Inc. (TARA) had Restricted Cash and Investments of $745.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Balance Sheet › Assets
us-gaap:RestrictedCashAndInvestments · last filed 2026-03-10
- 2025-12-31: Restricted Cash and Investments $745.00K.
- 2025-09-30: Restricted Cash and Investments $745.00K.
- 2025-06-30: Restricted Cash and Investments $745.00K.
- 2025-03-31: Restricted Cash and Investments $745.00K.
| Period end | Restricted Cash and Investments |
|---|---|
| 2025-12-31 | $745.00K 10-K · filed 2026-03-10 |
| 2025-09-30 | $745.00K 10-Q · filed 2025-11-10 |
| 2025-06-30 | $745.00K 10-Q · filed 2025-08-11 |
| 2025-03-31 | $745.00K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $745.00K 10-K · filed 2026-03-10 |
| 2024-09-30 | $745.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $745.00K 10-Q · filed 2024-08-06 |
| 2024-03-31 | $745.00K 10-Q · filed 2024-05-02 |
| 2023-12-31 | $745.00K 10-K · filed 2025-03-05 |
| 2023-09-30 | $745.00K 10-Q · filed 2023-11-03 |
| 2023-06-30 | $745.00K 10-Q · filed 2023-08-03 |
| 2023-03-31 | $745.00K 10-Q · filed 2023-05-04 |
| 2022-12-31 | $745.00K 10-K · filed 2024-03-13 |
| 2022-09-30 | $745.00K 10-Q · filed 2022-11-03 |
| 2022-06-30 | $745.00K 10-Q · filed 2022-08-09 |
| 2022-03-31 | $745.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $745.00K 10-K · filed 2023-03-08 |
| 2020-12-31 | $745.00K 10-K · filed 2021-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |